LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo could shrink skin tumors before surgery
Disease control Not yet recruitingThis study tests whether giving two drugs (a PD-1 inhibitor and an EGFR inhibitor) before surgery can shrink advanced skin cancer tumors enough to make surgery easier or even unnecessary. About 27 adults with borderline resectable skin cancer will receive up to 4 cycles of these …
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Melanoma and Skin Cancer Trials Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New shot therapy targets hard-to-treat skin cancer in phase 2 trial
Disease control Not yet recruitingThis study tests a new treatment for people with advanced skin cancer (squamous cell carcinoma) that has stopped responding to or cannot tolerate standard immunotherapy. The treatment is a combination of two drugs (L19IL2 and L19TNF) injected directly into the tumors once a week …
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC